Valiant Laboratories Statistics

Total Valuation

NSE:VALIANTLAB has a market cap or net worth of INR 4.92 billion. The enterprise value is 5.38 billion.

Market Cap	4.92B
Enterprise Value	5.38B

Important Dates

The next estimated earnings date is Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

NSE:VALIANTLAB has 43.45 million shares outstanding. The number of shares has increased by 13.57% in one year.

Current Share Class	43.45M
Shares Outstanding	43.45M
Shares Change (YoY)	+13.57%
Shares Change (QoQ)	+1.26%
Owned by Insiders (%)	30.44%
Owned by Institutions (%)	5.76%
Float	8.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.69
PB Ratio	2.10
P/TBV Ratio	2.10
P/FCF Ratio	n/a
P/OCF Ratio	374.52
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-244.21
EV / Sales	4.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.78

Financial Position

The company has a current ratio of 3.23, with a Debt / Equity ratio of 0.52.

Current Ratio	3.23
Quick Ratio	2.48
Debt / Equity	0.52
Debt / EBITDA	n/a
Debt / FCF	-1.08
Interest Coverage	-38.63

Financial Efficiency

Return on equity (ROE) is -0.93% and return on invested capital (ROIC) is -1.26%.

Return on Equity (ROE)	-0.93%
Return on Assets (ROA)	-1.14%
Return on Invested Capital (ROIC)	-1.26%
Return on Capital Employed (ROCE)	-1.98%
Revenue Per Employee	17.32M
Profits Per Employee	-285,870
Employee Count	77
Asset Turnover	0.36
Inventory Turnover	16.65

Taxes

In the past 12 months, NSE:VALIANTLAB has paid 6.89 million in taxes.

Income Tax	6.89M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.22% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-18.22%
50-Day Moving Average	105.89
200-Day Moving Average	104.72
Relative Strength Index (RSI)	54.83
Average Volume (20 Days)	45,619

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:VALIANTLAB had revenue of INR 1.33 billion and -22.01 million in losses. Loss per share was -0.51.

Revenue	1.33B
Gross Profit	167.82M
Operating Income	-67.72M
Pretax Income	-15.13M
Net Income	-22.01M
EBITDA	-46.79M
EBIT	-67.72M
Loss Per Share	-0.51

Full Income Statement

Balance Sheet

The company has 759.91 million in cash and 1.22 billion in debt, giving a net cash position of -456.96 million or -10.52 per share.

Cash & Cash Equivalents	759.91M
Total Debt	1.22B
Net Cash	-456.96M
Net Cash Per Share	-10.52
Equity (Book Value)	2.34B
Book Value Per Share	53.28
Working Capital	1.33B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.13 million and capital expenditures -1.14 billion, giving a free cash flow of -1.13 billion.

Operating Cash Flow	13.13M
Capital Expenditures	-1.14B
Free Cash Flow	-1.13B
FCF Per Share	-25.90

Full Cash Flow Statement

Margins

Gross margin is 12.58%, with operating and profit margins of -5.08% and -1.65%.

Gross Margin	12.58%
Operating Margin	-5.08%
Pretax Margin	-1.13%
Profit Margin	-1.65%
EBITDA Margin	-3.51%
EBIT Margin	-5.08%
FCF Margin	n/a

Dividends & Yields

NSE:VALIANTLAB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.57%
Shareholder Yield	n/a
Earnings Yield	-0.45%
FCF Yield	-22.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3